LENZ
LENZ Therapeutics
LENZ
LENZ
66 hedge funds and large institutions have $95.4M invested in LENZ Therapeutics in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 21 increasing their positions, 15 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
5% more funds holding
Funds holding: 63 → 66 (+3)
5% more capital invested
Capital invested by funds: $91.2M → $95.4M (+$4.24M)
0.19% less ownership
Funds ownership: 7.27% → 7.08% (-0.19%)
Holders
66
Holding in Top 10
2
Calls
$446K
Puts
$382K
Top Buyers
| 1 | +$13.7M | |
| 2 | +$1.86M | |
| 3 | +$359K | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$274K |
| 5 |
Man Group
London,
United Kingdom
|
+$241K |
Top Sellers
| 1 | -$12.5M | |
| 2 | -$1.83M | |
| 3 | -$809K | |
| 4 |
Goldman Sachs
New York
|
-$741K |
| 5 |
Millennium Management
New York
|
-$722K |